| Event chart VIR BIOTECHNOLOGY, INC. |
|
|
|
| Upcoming events on VIR BIOTECHNOLOGY, INC. |
|
| 08/16/22 | | Interim 2022 Earnings Release (Projected) |
| 11/15/22 | | Q3 2022 Earnings Release (Projected) |
| 02/23/23 | | FY 2022 Earnings Release (Projected) |
| 05/04/23 | | Q1 2023 Earnings Release (Projected) |
|
| Past events on VIR BIOTECHNOLOGY, INC. |
|
| 05/20/22 | | Annual General Meeting |
| 05/05/22 | 04:07pm | | Q1 2022 Earnings Release |
| 04/27/22 | 12:00pm | | Investor Day |
| 04/11/22 | 11:00am | | Needham Virtual Healthcare Conference |
| 03/09/22 | 10:30am | | Cowen & Co. Health Care Conference |
| 02/24/22 | 04:03pm | | FY 2021 Earnings Release |
| 01/11/22 | 01:30pm | | JP Morgan Healthcare Conference |
| 12/07/21 | 08:30am | | Sotrovimabs Update Call |
| 11/14/21 | 10:00am | | AASLD The Liver Meeting - Abstract No - 26144 |
| 11/12/21 | 08:00am | | AASLD The Liver Meeting - Abstract No - 28934 |
|
| Past dividends on VIR BIOTECHNOLOGY, INC. |
|
- No events available -
|
|
|
| Fiscal Period : December | 2019 | 2020 | 2021 | 2022 |
Sales
M $ |
Released
Forecast
Spread | 8,09
9,15
-12% | 76,4
79,3
-3,7% | 1 095
906
21% |
1 548
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | -173
-191
9,4% | -292
-274
-6,4% | 427
664
-36% |
1 071
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -178
-196
9,1% | -297
-280
-6,2% | 421
275
53% |
877
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -175
-193
9,4% | -299
-285
-4,7% | 550
463
19% |
738
|
Net income
M $ |
Released
Forecast
Spread | -175
-193
9,3% | -299
-284
-5,1% | 529
365
45% |
314
|
EPS
$ |
Released
Forecast
Spread | -5,76
-2,77
-108% | -2,51
-2,38
-5,3% | 3,96
2,74
44% |
2,31
| | Announcement Date | 03/26/2020 | 02/25/2021 | 02/24/2022 | - |
|
|
|
| Fiscal Period : December | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
Sales
M $ |
Released
Forecast
Spread | 5,72
2,93
95% | 67,0
3,90
1 620% | 1,93
11,0
-82% | 1,73
4,81
-64% | 1,98
98,6
-98% | 177
84,6
109% | 104
138
-25% | 813
623
30% | 1 232
811
52% |
185
|
85,8
|
63,8
|
22,4
|
43,8
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread |
|
| -86,5
-94,7
8,7% | -107
-92,7
-16% | -157
108
-246% | 62,3
-48,4
229% | -52,0
-11,7
-345% | 573
958
-40% |
369
|
12,3
|
-88,8
|
-23,5
|
-113
|
-95,2
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -71,9
-55,4
-30% | -29,1
-69,1
58% | -87,6
-83,8
-4,6% | -108
-92,7
-17% | -159
-38,4
-314% | 61,0
-51,4
219% | -53,4
1,30
-4 215% | 572
419
37% | 1 014
546
86% |
46,2
|
-59,7
|
-89,8
|
-116
|
-98,2
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -77,2
-54,4
-42% | -31,1
-68,1
54% | -84,6
-83,1
-1,8% | -106
-92,2
-15% | -169
-0,83
-20 146% | 61,9
-39,5
257% | 111
15,5
617% | 546
450
21% | 922
588
57% |
24,2
|
-80,9
|
-87,4
|
-114
|
-96,7
|
Net income
M $ |
Released
Forecast
Spread | -77,2
-54,5
-42% | -31,2
-68,2
54% | -84,6
-83,0
-2,0% | -106
-91,2
-16% | -169
-28,6
-490% | 61,8
-49,8
224% | 110
12,8
764% | 525
353
49% | 519
475
9,3% |
12,8
|
-94,9
|
-101
|
-87,0
|
-73,5
|
EPS
$ |
Released
Forecast
Spread | -0,71
-0,48
-47% | -0,27
-0,62
56% | -0,67
-0,59
-14% | -0,83
-0,72
-16% | -1,32
-0,01
-13 153% | 0,46
-0,41
212% | 0,82
0,08
874% | 3,92
2,63
49% | 3,85
3,54
8,8% |
0,04
|
-0,73
|
-0,82
|
-0,64
|
-0,54
| | Announcement Date | 05/12/2020 | 08/11/2020 | 11/10/2020 | 02/25/2021 | 05/06/2021 | 08/05/2021 | 11/04/2021 | 02/24/2022 | 05/05/2022 | - | - | - | - | - | |
|
|
| Upcoming sector events for VIR BIOTECHNOLOGY, INC. |
|
| |
|
| Past sector events for VIR BIOTECHNOLOGY, INC. |
|
| |
|
|
|
|
Pfizer's $11.6 billion Biohaven buy could spark more biotech deals |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
Previous year
